Abiraterone Impurity 16 - Request Quote
Abiraterone Impurity 16
| SZ CAT No: | SZ-A006077 |
| CAS No | NA |
| Mol.F. | C23H31NO4 |
| Mol.Wt. | 385.5 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Abiraterone Impurity 16 is chemically (3S,8R,9S,10R,13S,14S)-17-(1-(Hydroxyimino)ethyl)-10,13-dimethyl-7-oxo-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl acetate. Abiraterone Impurity 16 is supplied with detailed characterization data compliant with regulatory guideline. Abiraterone Impurity 16 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Abiraterone Acetate.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
buy high quality Abiraterone Impurity 16
Purchase Abiraterone Impurity 16
Abiraterone Impurity 16 suppliers
Abiraterone Impurity 16 manufacturers
Abiraterone Impurity 16 price
Order Abiraterone Impurity 16
Enquire Abiraterone Impurity 16
Abiraterone Impurity 16 cost
Abiraterone Impurity 16 Supplier
Abiraterone Impurity 16 Distributor
Abiraterone Impurity 16 for Method Validation
Abiraterone Acetate Reference Standard
Abiraterone Impurity 16 for ANDA Filing
Abiraterone Impurity 16 for Forced Degradation Studies
Abiraterone Impurity 16 Identification Standards
Abiraterone Impurity 16 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.